BALA CYNWYD, Pa., July 01, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

PlayAGS, Incorporated (NYSE - AGS)

Under the terms of the agreement, AGS will be acquired by affiliates of Brightstar Capital Partners (“Brightstar”) for $12.50 per share in cash. The investigation concerns whether the AGS Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration offers fair value to the Company’s shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/playags-incorporated-nyse-ags/.

RBAZ Bancorp, Inc. (OTCPK - RBAZ)

Under the terms of the agreement, RBAZ will be acquired by Pima Federal Credit Union (“Pima”). Pima will purchase substantially all of the assets and assume substantially all of the liabilities of Republic Bank in an all-cash transaction where RBAZ shareholders will receive $22.00 in cash for each share of stock they hold. The investigation concerns whether the RBAZ Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration offers fair value to the Company’s shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/rbaz-bancorp-inc-otcpk-rbaz/.

Avangrid, Inc. (NYSE - AGR)

Under the terms of the agreement, Avangrid will be acquired by its majority shareholder, Iberdrola, S.A. (“Iberdrola”). Iberdrola will acquire the remaining 18.4% of the issued and outstanding shares of common stock of Avangrid that it does not currently own for $35.75 per share in an all-cash transaction. The investigation concerns whether the Avangrid Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration offers fair value to the Company’s minority shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/avangrid-inc-nyse-agr/ .

Alimera Sciences, Inc. (Nasdaq - ALIM)

Under the terms of the agreement, Alimera will be acquired by ANI Pharmaceuticals, Inc. (“ANI”) (Nasdaq - ANIP) for $5.50 per share in cash at closing and one non-tradable contingent value right (CVR) representing the right to receive up to $0.50 per share upon the achievement of certain net revenue targets in 2026 and 2027. The investigation concerns whether Alimera Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether ANI is paying fair value to shareholders of the Company. For example, the up-front deal consideration is below the 52-week high of $5.65 for the Company’s shares.

Additional information can be found at https://www.brodskysmith.com/cases/alimera-sciences-inc-nasdaq-alim/.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.